November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
July 23, 2014
Saakashvili-led party seeking to ban broadcasts of Russian TV channels in Georgia
EBRD temporarily unable to approve new investment projects in Russia
EXISTENCE OF INSTRUCTION TO RECAPITALIZE GAZPROM MEANS THERE IS A NEED TO DO SO; THIS A QUESTION OF SOURCES - PUTIN AIDE
Kazakhmys may change name to KAZ Minerals PLC
IF MECHEL GOES BANKRUPT, SOME BANK CREDITORS WILL HAVE TO BE RECAPITALIZED, AND THIS IS UNDESIRABLE - PUTIN AIDE
Daily Headline News for July 23, 2014
Astakhov wants to find out how Italian, who killed boy adopted from Russia, got wrong medical certificate
IMPORTANT WHEN EXPORTING GAS THAT THERE IS NO RIVALRY BETWEEN RUSSIAN COMPANIES - PUTIN AIDE
Medvedev: no plans to shutter trade representations; new ones to open as needed
PIPELINE GAS EXPORT MONOPOLY REMAINS UNSHAKABLE - PUTIN AIDE
Russia needs breakthrough in cooperation with Asian investors - PM (Part 2)
PUTIN AIDE HOPES RUSSIAN GDP WILL GROW APPROX 1% THIS YEAR, DESPITE SANCTIONS
ISSUE OF FURTHER ACTION WITH REGARD TO MECHEL TO BE RESOLVED THIS WEEK - BELOUSOV